FDA Drug recall D-1346-2015
Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India
- FDA Drug
- Class II
- terminated
- Published 2015-08-26
On 2015-08-26 the FDA classified a Class II recall of Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India by Wockhardt Usa, citing CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1346-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-29 |
| Published | 2015-08-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Wockhardt Usa |
| Distribution | US |
Product
Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 92806 6, NDC 64679-928-06.
Reason
CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Identifiers
| upc | 364679928066 |
|---|---|
| code_info | Lot #: DM12700, Exp 09/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1346-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.